PubRank

S Jolles

Author PubWeight™ 18.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy. Clin Exp Immunol 2012 1.36
2 Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology. Clin Exp Immunol 2009 1.16
3 Immunomodulatory action of intravenous immunoglobulin. Immunology 2002 1.14
4 The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012. Clin Exp Immunol 2014 1.08
5 Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000 0.93
6 Clinical immunology review series: an approach to the patient with anaphylaxis. Clin Exp Immunol 2008 0.87
7 Management of aseptic meningitis secondary to intravenous immunoglobulin. BMJ 1998 0.86
8 Clinical immunology review series: an approach to the use of the immunology laboratory in the diagnosis of clinical allergy. Clin Exp Immunol 2008 0.85
9 The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis. Clin Exp Immunol 2014 0.85
10 Zulu ritual immunisation in perspective. Africa (Lond) 2000 0.82
11 High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders. Clin Exp Immunol 2002 0.81
12 Paul Langerhans. J Clin Pathol 2002 0.81
13 Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab. J Clin Pathol 2007 0.80
14 The application of a PCR technique for the detection of immunoglobulin heavy chain gene rearrangements in fresh or paraffin-embedded skin tissue. Pathology 2001 0.79
15 Primary HIV-1 infection: a new medical emergency? BMJ 1996 0.79
16 A recipient of immunoglobulin from a donor who developed vCJD. Vox Sang 2009 0.77
17 African traditional medicine--potential route for viral transmission? Lancet 1998 0.77
18 Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin. J Clin Pathol 2006 0.76
19 Importance of trial design in studies using high-dose intravenous immunoglobulin. Br J Dermatol 2003 0.76
20 Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgaris. J Am Acad Dermatol 1999 0.76
21 Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum. Br J Dermatol 1999 0.75
22 [Sampling in epidemiological research with a note on fertility]. Union Med Can 1972 0.75
23 [Recurrent meningitis and inherited complement deficiency]. Epidemiol Mikrobiol Imunol 2016 0.75
24 7th International Immunoglobulin Conference: Foreword. Clin Exp Immunol 2014 0.75
25 Successful dietary treatment of recurrent intussusception. Arch Dis Child 2009 0.75
26 The role of complement testing in dermatology. Clin Exp Dermatol 2005 0.75